Disease-associated vision changes are common in GCA, with no significant difference in visual improvement observed with IV glucocorticoids vs oral therapy.

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men. HealthDay News — Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, ...

Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among patients with idiopathic intracranial hypertension (IIH).

Extended dosing of dupilumab in patients with AD has similar efficacy as standard dosing, with no significant affect seen on ocular adverse events.

The Trump administration is taking steps to roll back state laws that protect consumers from having medical debt appear on their credit reports.

Access to nutritious food through SNAP slows cognitive decline, but barriers limit the program's reach and effectiveness on ...

A home tonometer is effective for detecting diurnal fluctuations and out-of-office intraocular pressure spikes for patients at glaucoma risk.

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...

HealthDay News — Machine learning (ML) outperforms human graders for diagnosing glaucoma, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct.

While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.